Facing Existential Challenges, WHO Shuts Down its Policy, Law, and Human Rights Unit
Global activists react to the news and vow to keep up the fight for human rights in mental health.
UberTherapy and the Enshittification of our Relational Lives: Part 2 of our Interview with...
Elizabeth Cotton traces how digital therapy can block the very thing people come for: a stable, human relationship that can hold fear, dependency, and ambivalence.
The FDA Allows Ineffective Devices to Come to Market
“The main take-home message is that regulatory approval doesn't mean a device works. It means it's safe,” according to Katya Rubia, PhD.
UberTherapy and the Enshittification of our Relational Lives: Part 1 of our Interview with...
With UberTherapy, Elizabeth Cotton follows the gig-economy playbook into psychotherapy, where platforms lower costs by depressing wages and standardizing treatment.
Visual Snow Syndrome: Can SSRIs Literally Change How You See the World?
SSRI antidepressants have been linked to a number of adverse effects. A recent study presents evidence that a new condition may need to be...
Food First, Pharma Last: Part Two of our Interview with Chris Masterjohn
Chris Masterjohn joins us to discuss the biochemistry of our stress response and the potential benefits of balanced nutrition for those in psychiatric drug withdrawal.
Mitochondria and Energetic Failures: A New Understanding of Antidepressant Withdrawal? An Interview With Chris...
Chris Masterjohn joins us to discuss the importance of our mitochondria, the role of serotonin in our body and whether a new understanding of antidepressant withdrawal is urgently needed.
Why Critical Mental Health Knowledge Is Essential for Ethical Practice: An Interview with Jan...
In this conversation, Jan DeFehr argues that ethical practice requires access to what the field itself disputes, including the risks people rarely hear about.
ADHD Diagnoses, Examining the Psyche, Withdrawal and PSSD Risks, ECT Harms and More: Robert...
In our first podcast of 2026, Robert Whitaker joins us to answer questions submitted by Mad in America readers and listeners. We discuss the validity of ADHD diagnoses, withdrawal and sexual dysfunction risks of SSRI antidepressants, the harms of electro-convulsive therapy (ECT), the rise of AI-generated misinformation and much more.
To Be Agents of Our Own Treatment: Demedicalization at the Heart of the Inner...
We are fighting for transparency, accountable science, and for the rights of the common people who are misinformed, as we require informed consent.
Psychiatry’s Rightwing and Progressive Bigotries: How Each Enables the Megamachine
Whether in Nazi fascism, Soviet totalitarian communism, or U.S. corporate capitalism, psychiatry has been an enabler of the megamachine.
Learning to Soar: A Conversation With Artist Kev G Mor
Musician and artist Kev G Mor joins us to discuss his experience of psychosis, his daily support strategies, and the pros and cons of having a pit bull for emotional support.
Medication-Free Treatment in Norway Found Effective Over the Short Term
Those who received drug-tapering support did just as well or better than those receiving treatment as usual.
The APA Opposes Written Informed Consent for Veterans
The American Psychiatric Association and other prominent medical associations are lining up in opposition to proposed legislation that would require prescribers of psychiatric medication to obtain signed consent from veterans acknowledging the side effects and risks of psychiatric drugs.
Connecticut’s Forced Electroshock Problem
Unpacking forced electroshock data obtained from the State of Connecticut Office of the Probate Court Administrator.
The Damage Doesn’t End When the Drugs Do: Diana Rose on Psychiatry’s Long Shadow
Ayurdhi Dhar interviews survivor-researcher Diana Rose on her long-term adverse experiences from psychiatric drugs, survivor knowledge, and the humiliations built into the system.
Antidepressant Withdrawal: Finding an Astronomical Perspective – A Conversation with Safa Askeri
Maybe you have this interpretation that you're not going to recover and you have permanent damage, but it's not like that. I'm very hopeful.
Commentary: Does First Year Treatment With an Antipsychotic Lead to Long-Term Harm?
There is no good evidence that antipsychotics provide a benefit to first-episode or early-episode psychotic patients.
New Evidence in Support of Tapering Protocols for First-Episode Psychosis
The study shows that tapering can be successfully and relatively safely done by most people after first-episode psychosis.
Special Issue: Class and Psychoanalysis
A wide-ranging, interdisciplinary exploration of class and labor in psychoanalytic thinking and the psychoanalytic professional field.
Psychiatric Drugs: The Real World is Where the Harms Live
Joining us for a roundtable discussion are Brooke Siem, David Antonuccio, Kim Witzak, Angie Peacock and David Healy. They discuss the challenges of openly discussing psychiatric drug withdrawal, the meaning of informed consent, getting doctors to acknowledge medication-induced harm and much more.
How Radical Activism Transformed Mental Health in Brazil
Anti-asylum movement in Brazil led to creation of a national network of community centers, which stands in contrast to the failed mental health system in the United States.
Medical Organizations Turn Blind Eye to Harms of Maternal Antidepressant Use: A Conversation With...
Adam Urato and Joanna Moncrieff join Robert Whitaker on the Mad in America podcast to discuss the risks posed by maternal use of antidepressants.
A Call for Evidence-Based, Fear-Free Practice
It is right to criticize MAHA, but poorly researched, fear-based responses by mainstream psychiatry only further mislead the public.
Fifty Years of Grief
September 27, 2025, is the fiftieth anniversary of the ignominious death in prison of my sorely regretted and dearly beloved friend Mark Frechette.
